Infliximab for Immune Checkpoint Inhibitor Associated AKI

Clinical trial NCT07683975 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07683975
Sponsor: Massachusetts General Hospital
Status: NOT_YET_RECRUITING
Phase: Phase 4
Study type: INTERVENTIONAL

Acute Kidney Injury Acute Interstitial Nephritis

Start date: 2026-07-16
Primary completion: 2029-01-15
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.